Net Cash Provided by (Used in) Operating Activities |
24.6M |
USD |
-38.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-159M |
USD |
-39.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
79.4M |
USD |
+14.1% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-55.8M |
USD |
-957% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
289M |
USD |
-4.63% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
13.8M |
USD |
+71.2% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
16.9M |
USD |
+47.7% |
Q4 2023 |
FY 2023 |
Operating Lease, Liability |
25.8M |
USD |
+6.47% |
Q2 2024 |
Q2 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-128M |
USD |
-288% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
-137K |
USD |
-186% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
35.4M |
USD |
+445% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
3.12M |
USD |
-8.1% |
Q4 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
14M |
USD |
+53.3% |
Q2 2024 |
Q2 2024 |
Interest Expense |
165M |
USD |
+2.31% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |